A targeted approach to hepatitis B vaccination for newborns may increase infections unless screening rates improve dramatically.
Study Warns Against Replacing Universal Hepatitis B Vaccine for Newborns
A new study has estimated the potential impact of shifting from the current universal hepatitis B virus (HBV) birth-dose vaccination policy in the United States to a targeted recommendation.
The core finding is that such a targeted policy is likely to lead to a rise in neonatal infections, unless two critical conditions are met: maternal screening rates must increase substantially, or vaccination coverage among infants born to unscreened mothers must exceed current levels.
Based on historical data, the study suggests these improvements are unlikely. This reinforces the continued importance of universal screening and vaccination as complementary safeguards that protect newborns from infection.